20 years of experimental research in HTTG and LEBAO

From organ transplantation to (bio)artificial organ replacement

Since under the direction of Hans Georg Borst, the Department of Cardiothoracic, Transplantation and Vascular Surgery (HTTG) of the Hannover Medical School has been famous for being one of the leading surgical clinics in Europe. In 1996, leadership was taken over by Prof. Dr. Axel Haverich and since then both the clinical and scientific research aspects have been further advanced and as a result, the entire department is currently counted among the strongest research surgical clinics worldwide. The broad range of experimental research is especially striking. These achievements, as well as the close bond between application-driven basic research and clinical practice, are the result of the 2007 newly introduced dual leadership concept, including a clinical director (Prof. Dr. med. Dr. h.c. A. Haverich) and a research director (Prof. Dr. rer. nat. U. Martin). This impressive development is most certainly also a result of the foundation of the LEBAO in 1996, based on funding from the prestigious Leibniz prize by the DFG, which was awarded to Prof. Haverich due to his achievements for the conservation of lung donations.

Together with invited guests, on 18 November 2016, we will look back on 20 years of very successful surgical research within the HTTG.